المؤلفون: Alexander Lim, Salvatore Michael Bottiglieri, Kunhwa Kim, Richard D. Kim, Dae-Won Kim

المصدر: Journal of Clinical Oncology. 37:251-251

مصطلحات موضوعية: Oncology, Cancer Research, Chemotherapy, medicine.medical_specialty, Standard of care, business.industry, medicine.medical_treatment, Combination chemotherapy, Dose intensity, Gemcitabine, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Paclitaxel, chemistry, 030220 oncology & carcinogenesis, Internal medicine, Metastatic pancreatic cancer, Medicine, business, 030215 immunology, Nab-paclitaxel, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::a3c95d44a7763c9ff44c3a63e61be4f9Test
https://doi.org/10.1200/jco.2019.37.4_suppl.251Test

المؤلفون: Colin D. Weekes, Carlos Fernandez-del Castillo, Lorraine C. Drapek, Jill N. Allen, David P. Ryan, Cristina R. Ferrone, Leilana Ly, Jennifer Y. Wo, Eunice L. Kwak, Andrew X. Zhu, Ryan D. Nipp, Lawrence S. Blaszkowsky, Janet E. Murphy, Lipika Goyal, Beow Y. Yeap, Jeffrey W. Clark, Thomas F. DeLaney, Jason E. Faris, Ryan B. Corcoran, Aparna Raj Parikh

المصدر: Journal of Clinical Oncology. 37:392-392

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, FOLFIRINOX, business.industry, medicine.medical_treatment, Dose intensity, Locally advanced pancreatic cancer, Borderline resectable, Internal medicine, medicine, business, Adjuvant

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::be3a8e7cc5e14317590d67d01dd9975cTest
https://doi.org/10.1200/jco.2019.37.4_suppl.392Test

المؤلفون: Pax H.B. Willemse, Elisabeth G.E. de Vries, Winette T. A. van der Graaf, Michael Schaapveld, Renée Otter

المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS)

المصدر: Journal of cancer research and clinical oncology, 130(10), 581-590. SPRINGER

مصطلحات موضوعية: Oncology, Cancer Research, Quality Assurance, Health Care, medicine.medical_treatment, Medical Oncology, chemotherapy, Antineoplastic Combined Chemotherapy Protocols, CYCLOPHOSPHAMIDE, CONSERVATIVE SURGERY, pattern of care, General Medicine, Middle Aged, Combined Modality Therapy, METHOTREXATE, Fluorouracil, Chemotherapy, Adjuvant, Lymphatic Metastasis, Female, EARLY-STAGE, TRIAL, Guideline Adherence, guideline, medicine.drug, Adult, medicine.medical_specialty, Cyclophosphamide, relative dose intensity, Breast Neoplasms, Guidelines as Topic, Breast cancer, breast cancer, Internal medicine, RADIATION-THERAPY, medicine, MANAGEMENT, Humans, radiotherapy, Retrospective Studies, Chemotherapy, business.industry, Cancer, Retrospective cohort study, DOSE INTENSITY, Guideline, medicine.disease, Survival Analysis, Surgery, Radiation therapy, 5-FLUOROURACIL CMF, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d307cc5308cd778fe27ff597174c80e1Test
https://research.rug.nl/en/publications/74488448-4fb4-4e2a-ad7a-8b803234a51eTest

المؤلفون: Kun Wang, Lianyu Chen, Zhenhua Zhou, Junhua Lin, Peng Wang, Zheng Chen, Zhiqiang Meng

المصدر: International Journal of Hyperthermia. 28:645-652

مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Physiology, medicine.medical_treatment, Physiology (medical), Pancreatic cancer, Female patient, medicine, Humans, Dosimetry, Hifu ablation, Aged, Ultrasonography, Aged, 80 and over, business.industry, Ultrasound, Middle Aged, medicine.disease, Dose intensity, High-intensity focused ultrasound, Pancreatic Neoplasms, Treatment Outcome, High-Intensity Focused Ultrasound Ablation, Female, Clinical dosimetry, Radiology, Nuclear medicine, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c889a3327950b1150343167a1c1de04Test
https://doi.org/10.3109/02656736.2012.713541Test

المؤلفون: Chikako Shimizu, Kan Yonemori, Ako Hosono, Atsushi Makimoto, Yuki Kojima, Masashi Ando, Makoto Kodaira, Harukaze Yamamoto, Yasuhiro Fujiwara, Kenji Tamura, Mayu Yunokawa, Kenji Hashimoto

المصدر: Cancer Chemotherapy and Pharmacology. 70:391-397

مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Vincristine, Adolescent, Cyclophosphamide, medicine.medical_treatment, Toxicology, Adult rhabdomyosarcoma, Gastroenterology, Young Adult, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Rhabdomyosarcoma, Retrospective analysis, Humans, Medicine, Pharmacology (medical), Child, Aged, Retrospective Studies, Pharmacology, Chemotherapy, Dose-Response Relationship, Drug, business.industry, Age Factors, Middle Aged, Prognosis, medicine.disease, Dose intensity, Surgery, Regimen, Treatment Outcome, Peripheral neuropathy, Oncology, Child, Preschool, Dactinomycin, Feasibility Studies, Female, business, Follow-Up Studies, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cf531ea29273d35f5c802732873b6b3Test
https://doi.org/10.1007/s00280-012-1920-0Test

المؤلفون: Purvish M. Parikh, Sachin Hingmire, Narayanan Prasad, A. Bakshi, AA Ranade, Chetan Deshmukh

المصدر: South Asian Journal of Cancer
South Asian Journal of Cancer, Vol 01, Iss 01, Pp 09-15 (2012)

مصطلحات موضوعية: Response rate (survey), Oncology, medical oncologist, response rate, Cancer Research, Chemotherapy, medicine.medical_specialty, prolonged infusion, business.industry, medicine.medical_treatment, Cancer, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, chemotherapy, medicine.disease, lcsh:RC254-282, Dose intensity, Systemic therapy, Internal medicine, Palliative intent, Medicine, Original Article, Non small cell, business, Lung cancer

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e05d0beb44456163ca43657f01e3b22Test
https://doi.org/10.4103/2278-330x.96494Test

المؤلفون: Cécile Borel, Pauline Jeanneau, Eric Bauvin, Guy Laurent, Fabien Despas, Jean Claude Nogaro, Gisèle Compaci, Cyrille Delpierre, Sébastien Lamy, Christian Recher

المساهمون: Service d'hématologie [Tours], Centre Hospitalier Régional Universitaire de Tours (CHRU Tours)-Hôpital Bretonneau, Service d'hématologie, Institut Universitaire du Cancer de Toulouse - Oncopole (IUCT Oncopole - UMR 1037), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse]-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse]-Institut National de la Santé et de la Recherche Médicale (INSERM), Epidémiologie et analyses en santé publique : risques, maladies chroniques et handicaps (LEASP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées, Service de Pharmacologie Clinique, Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Hôpital Purpan [Toulouse], CHU Toulouse [Toulouse]-CHU Toulouse [Toulouse], Centre de Recherches en Cancérologie de Toulouse (CRCT), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Réseau de Cancérologie de Midi-Pyrénées, Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse]-Institut National de la Santé et de la Recherche Médicale (INSERM)-Réseau Oncomip, Institut Universitaire du Cancer Toulouse - Oncopôle (IUCT)-Institut Universitaire du Cancer Toulouse - Oncopôle (IUCT), CHU Toulouse [Toulouse]-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Toulouse [Toulouse]-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Réseau Oncomip, BMC, BMC, Service Hématologie - IUCT-Oncopole [CHU Toulouse], Pôle Biologie [CHU Toulouse], Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Pôle IUCT [CHU Toulouse], Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Service Pharmacologie Clinique [CHU Toulouse], Pôle Santé publique et médecine publique [CHU Toulouse], Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Réseau Oncomip

المصدر: BMC Cancer
BMC Cancer, BioMed Central, 2015, 15 (1), pp.288. ⟨10.1186/s12885-015-1287-9⟩
BMC Cancer, 2015, 15 (1), pp.288. ⟨10.1186/s12885-015-1287-9⟩

مصطلحات موضوعية: Male, Longitudinal study, Cancer Research, Lymphoma, [SDV]Life Sciences [q-bio], Comorbidity, Kaplan-Meier Estimate, Antibodies, Monoclonal, Murine-Derived, 0302 clinical medicine, Prednisone, Non-medical determinant of health, Antineoplastic Combined Chemotherapy Protocols, Treatment adherence, Overall survival, Longitudinal Studies, Aged, 80 and over, Medical record, Middle Aged, 3. Good health, [SDV] Life Sciences [q-bio], Treatment Outcome, Oncology, Vincristine, 030220 oncology & carcinogenesis, Cohort, Rituximab, Female, France, Lymphoma, Large B-Cell, Diffuse, medicine.drug, Research Article, Adult, medicine.medical_specialty, Medication Adherence, 03 medical and health sciences, Internal medicine, Relative dose-intensity, medicine, Genetics, Humans, Mortality, Cyclophosphamide, Aged, Neoplasm Staging, business.industry, medicine.disease, Surgery, Socioeconomic Factors, Doxorubicin, business, Diffuse large B-cell lymphoma, 030215 immunology

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a920fac653034939dca09922ae84af1Test
https://www.hal.inserm.fr/inserm-01264475/documentTest

المؤلفون: Eddie Reed, Elise C. Kohn, Annette Bicher, Patricia Davis, Debra O. Adamo, Bruce A. Chabner, Gisele Sarosy, Joan Jacob

المصدر: Cancer. 71:594-600

مصطلحات موضوعية: Adult, Oncology, Aging, Cancer Research, medicine.medical_specialty, Paclitaxel, endocrine system diseases, medicine.medical_treatment, Ovary, Drug Administration Schedule, Cohort Studies, Internal medicine, Granulocyte Colony-Stimulating Factor, medicine, Humans, Aged, Ovarian Neoplasms, Chemotherapy, Dose-Response Relationship, Drug, biology, business.industry, Recurrent Carcinoma, Middle Aged, medicine.disease, biology.organism_classification, Dose intensity, Surgery, Clinical trial, Taxus brevifolia, medicine.anatomical_structure, Female, Neoplasm Recurrence, Local, Ovarian cancer, business, Cohort study

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02a46b3813fdab25d239af6e34c93ae8Test
https://doi.org/10.1002/cncr.2820710216Test

المؤلفون: Kheda Elsnukaeva, Alexey Tryakin, Ilya Pokataev, Mikhail Fedyanin, Anna Popova, Dzhennet Chekini, Olga Sekhina, Anatoly Bulanov, Sergei Tjulandin

المصدر: Journal of Clinical Oncology. 36:e15523-e15523

مصطلحات موضوعية: Oncology, Cancer Research, Chemotherapy, medicine.medical_specialty, Colorectal cancer, business.industry, medicine.medical_treatment, medicine.disease, Dose intensity, Oxaliplatin, Irinotecan, Internal medicine, medicine, Line (text file), business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::76cff2348c411b982af43ccc0cb4a7f4Test
https://doi.org/10.1200/jco.2018.36.15_suppl.e15523Test

المؤلفون: Ewa Łątka, Tomasz Ogórka, Aleksander B. Skotnicki, Monika Długosz-Danecka, Katarzyna Krawczyk, Wojciech Jurczak, Sebastian Szmit

المصدر: Journal of Clinical Oncology. 36:e19542-e19542

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Prognostic factor, business.industry, medicine.disease, Dose intensity, Lymphoma, International Prognostic Index, immune system diseases, hemic and lymphatic diseases, Internal medicine, medicine, Overall survival, business, Diffuse large B-cell lymphoma

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::bba04b21f605369ce298f016d7af9b9aTest
https://doi.org/10.1200/jco.2018.36.15_suppl.e19542Test